Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shikhar Mehrotra

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Science Translational Medicine|October 30, 2015
IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapyEe W Su, Caitlin J Moore, Samantha Suriano, et al.
Cancer Immunology, Immunotherapy : CII|February 14, 2015
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cellsMark P Rubinstein, Ee Wern Su, Samantha Suriano, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma modelArvind Chhabra, Lili Yang, Pin Wang, et al.
Cell Reports|December 8, 2022
Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasisAlhaji H Janneh, Mohamed Faisal Kassir, F Cansu Atilgan, et al.
Cancer Research|August 7, 2025
Alzheimer's Disease-Associated Amyloid Beta Precursor Protein Prevents Aging Stress-Induced Mitophagy and Fumarate Depletion to Improve Anti-Tumor ImmunityMohamed Faisal Kassir, Han Gyul Lee, Natalia V Oleinik, et al.
Science Advances|September 16, 2020
Identification of human CD4<sup>+</sup> T cell populations with distinct antitumor activityMichelle H Nelson, Hannah M Knochelmann, Stefanie R Bailey, et al.
Leukemia|May 5, 2022
Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathwayM Hanief Sofi, Linlu Tian, Steven Schutt, et al.
Cell Reports|March 31, 2023
Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistanceXueliang Gao, Yongxia Wu, Joel M Chick, et al.
The Journal of Biological Chemistry|April 12, 2019
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cellsParamita Chakraborty, Shilpak Chatterjee, Pravin Kesarwani, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Science Translational Medicine|October 30, 2015
IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapyEe W Su, Caitlin J Moore, Samantha Suriano, et al.
Cancer Immunology, Immunotherapy : CII|February 14, 2015
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cellsMark P Rubinstein, Ee Wern Su, Samantha Suriano, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma modelArvind Chhabra, Lili Yang, Pin Wang, et al.
Cell Reports|December 8, 2022
Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasisAlhaji H Janneh, Mohamed Faisal Kassir, F Cansu Atilgan, et al.
Cancer Research|August 7, 2025
Alzheimer's Disease-Associated Amyloid Beta Precursor Protein Prevents Aging Stress-Induced Mitophagy and Fumarate Depletion to Improve Anti-Tumor ImmunityMohamed Faisal Kassir, Han Gyul Lee, Natalia V Oleinik, et al.
Science Advances|September 16, 2020
Identification of human CD4<sup>+</sup> T cell populations with distinct antitumor activityMichelle H Nelson, Hannah M Knochelmann, Stefanie R Bailey, et al.
Leukemia|May 5, 2022
Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathwayM Hanief Sofi, Linlu Tian, Steven Schutt, et al.
Cell Reports|March 31, 2023
Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistanceXueliang Gao, Yongxia Wu, Joel M Chick, et al.
The Journal of Biological Chemistry|April 12, 2019
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cellsParamita Chakraborty, Shilpak Chatterjee, Pravin Kesarwani, et al.
Pageof 12